MedDataX Logo

Tracheotomy With and Without Dual Antiplatelet Therapy

NCT ID: NCT05058469

Last Updated: 2024-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Platelet-inhibiting drugs are often used after vascular interventions. Patients who require such therapies are often critically ill, are treated in intensive care units and often require long-term ventilation. For long-term ventilation a tracheotomy is necessary, which is usually performed as a percutaneous dilatative tracheotomy (PDT). As part of this intervention, there is (theoretically) an increased risk of bleeding/an increased rate of complications in patients with a antiplatelet therapy. In addition, there are various techniques for performing a PDT.

The current study aims to investigate the frequency of bleeding/complications taking into account the technique used in PDT.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery

NCT01358422

Bleeding Thrombosis Cardiac Events
COMPLETED

Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery

NCT02940444

Thromboprophylaxis Thoracic Surgery
UNKNOWN PHASE1/PHASE2

Tranexamic Acid and Drain Use in Knee Arthroplasty

NCT07174895

Osteoarthritis, Knee
COMPLETED NA

IV Tranexamic Acid Prior to Hysterectomy

NCT02911831

Hysterectomy Blood Loss, Surgical
COMPLETED EARLY_PHASE1

Intravenous Tranexamic Acid During Rhytidectomy

NCT03970213

Bleeding Bruising Face Swelling Lips & Face
UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tracheostomy Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tracheotomy without antiplatelet therapy+technique 1

Tracheotomy

Intervention Type DEVICE

Tracheotomy in patients +/- antiplatelet therapy

Tracheotomy under antiplatelet therapy+technique 1

Tracheotomy

Intervention Type DEVICE

Tracheotomy in patients +/- antiplatelet therapy

Tracheotomy without antiplatelet therapy+technique 2

Tracheotomy

Intervention Type DEVICE

Tracheotomy in patients +/- antiplatelet therapy

Tracheotomy under antiplatelet therapy+technique 2

Tracheotomy

Intervention Type DEVICE

Tracheotomy in patients +/- antiplatelet therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tracheotomy

Tracheotomy in patients +/- antiplatelet therapy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who underwent Percutaneous Dilational Tracheostomy

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asklepios Neurological Clinic Bad Salzhausen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Neurologische Klinik Bad Salzhausen

Nidda, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dirk Bandorski, MD

Role: CONTACT

[email protected]
+496043804212

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dirk Bandorski, MD

Role: primary

[email protected]
+496043804212

Jens Allendörfer, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PDT and (D)APT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty
NCT02504125 COMPLETED PHASE4
Thromboelastometry Guided DIC Prevention After Cesarean Section in Pregnant Women With Placenta Previa
NCT03266432 UNKNOWN NA
The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach
NCT01622946 COMPLETED PHASE4
The Efficacy and Safety of Using Tranexamic Acid by Different Means to Reduce Blood Loss During Total Knee Replacement
NCT02117128 COMPLETED PHASE4
Evaluation of TXA Prior to Surgery in the Geriatric Hip Fracture Population
NCT03923959 COMPLETED PHASE3
The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery
NCT02684851 COMPLETED PHASE3
Coagulopathy in Cardiac Surgery
NCT03475940 COMPLETED
Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery
NCT02097602 COMPLETED
Thromboelastogram During Total Knee Replacement
NCT02373969 COMPLETED
Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
NCT02238444 UNKNOWN PHASE4
Efficacy of Topical Versus Intravenous Tranexamic Acid in Controlling Blood Loss
NCT06188052 RECRUITING PHASE4
Suction Drainage in the Management of Peri-operative Bleeding in Total and Unicomcompartmental Knee Arthroplasty
NCT04508101 UNKNOWN
Reduction Bleeding in Laminectomy With Double Doses of Tranexamic Acid
NCT01643135 COMPLETED PHASE4
Blood Loss Assessment in the Limited Application of Tourniquet During Primary Unilateral TKA
NCT05691751 COMPLETED NA
Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty
NCT02427412 COMPLETED PHASE4
Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement
NCT01850394 COMPLETED NA
Effects of an Early Prehospital Administration of Tranexamic Acid on Hyperfibrinolysis in Multiple Trauma
NCT01938768 COMPLETED
The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery
NCT01707459 COMPLETED
Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger
NCT06187831 RECRUITING
Tranexamic Acid and Blood Clots in Knee Surgery
NCT02867163 COMPLETED
Trauma Associated Bleeding: Effectiveness of an Early Coagulation Support Protocol
NCT03354559 COMPLETED
Study of the Effect of Differing Platelet Transfusion Times in Neonates
NCT00948792 COMPLETED NA
Haemorrhage From Severe Neck and Facial Injuries - Characteristics, Management and Outcomes
NCT07204405 COMPLETED
Effect of Suction Drains in Total Knee Arthroplasty With Tranexamic Acid
NCT03145493 COMPLETED NA
Fibrinogen Early In Severe Trauma studY
NCT02745041 COMPLETED PHASE2